US 9,211,181 · Application 13/625,615 · Granted Dec 15, 2015
US 9,211,181
Implant loading device and system
Estimated expiration
January 12, 2027
107 days remaining
Earliest effective filing
Nov 18, 2005
+ 20 years
Nov 18, 2025
PTA +420d
Jan 12, 2027
No TD
—
Final
Jan 12, 2027
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- September 24, 2012
- Earliest effective filing
- November 18, 2005
- Issue date
- December 15, 2015
- PTA
- +420 days
- Base expiry (before PTA)
- November 18, 2025
November 18, 2005 + 20 years = November 18, 2025 + 420 PTA days = January 12, 2027
- Continuation-in-part of application 12/820,393, filed Jun 22, 2010, issued as US 8,388,682
- Continuation of application 11/282,940, filed Nov 18, 2005, issued as US 7,771,472
- PRO61/538,723 — Provisional — not used for base term
- PRO60/630,399 — Provisional — not used for base term
- PRO60/630,399 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/625,615 · US 9,211,181
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,211,181: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9211181Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.